Selective modulation of cell adhesion molecules on lymphocytes by bromelain protease 5

Pathobiology

Volumn 64, Issue 6, 1996, Pages 339-346

  Kleef, R ^a   Delohery, T M ^a   Bovbjerg, D H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bromelain; Cell adhesion molecules; Proteolytic enzymes

Indexed keywords

BROMELAIN; CD11B ANTIGEN; CD16 ANTIGEN; CD56 ANTIGEN; CELL ADHESION MOLECULE; GLYCOPROTEIN P 15095; HERMES ANTIGEN; INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PADGEM PROTEIN; PROTEINASE;

ADULT; ARTICLE; CANCER; CELL SURFACE; CHRONIC INFLAMMATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030440888     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000164070     Document Type: Article

References (39)

1. Taussig SJ, Szekerezes J, Batkin S: Bromelain, the enzyme complex of pineapple (Ananas co-mosus) and its clinical application, An update, J Ethnopharmacol 1988;22:191-203.
2. Brocklehurst K, Willcnbrock F, Salih E: Cysteine proteinases: in Neuberger A, Brocklehurst K (eds): Hydrolytic Enzymes, New York, Elsevier, 1987. p 39.
3. Harrach T, Eckert K, Schulze-Forster K, Nuck R, Grunow D, Mauer HR: Isolation and partial characterization of basic proteinases from stem bromelain, J Protein Chem 1995:14:41-51.
4. Gardner MLG, Steffens KJ (eds): Absorption of Orally Administered Enzymes, Berlin, Springer, 1995.
5. Stauder G, Ransberger K, Streichhan P, Van Schaik W, Pollingcr W: The use of hydrolytic enzymes as adjuvant therapy in AIDS/ARC/LAS patients, Biomed Pharmacother 1988:42: 31-34.
6. v Rokitansky O, Stauder G, Streichhan P: En-zymthcrapic als prae-und postopcratives Adju-vans bei der Bruslkrebsbehandlung, Dtsch Z Onkol/J Oncol 1993;25:130-136.
7. Hale LP, Haynes BF: Bromelain treatment of human T cells removes CD44. CD45RA, E2/ MIC2. CD6. CD7. CD8. and Leu 8/LAM I surface molecules and markedly enhances CD2-mediatcd T cell activation, J Immunol 1992: 149:3809-3816.
8. Munzig E, Eckert K, Harrach T, Graf H, Maurer HR: Bromelain protease F9 reduces the CD44 mediated adhesion of human peripheral blood lymphocytes to humen umbilical vein endothelial cells, FEBS Lett 1994:351:215-218.
9. Mackay CR, lmhof BA: Cell adhesion in the immune system, Immunol Today 1993; 14:99-102.
10. Hogg N, Berlin C: Structure and function of adhesion receptors in leukocyte trafficking, Immunol Today 1995; 16(7):327-330.
11. Hamblin A, Taylor M, Bernhagen J, Shakoor Z, Mayall S, Noble G, McCarthy D: A method of preparing blood leukocytes for llow cytometry which prevents uprcgulation of leukocyte integrins, J Methods 1992:146:219-228.
12. Rocderer M, Landay A: Flow Cytometric Evaluation in AIDS, The Handbook of Experimental Immunology, ed 5. in press.
13. Stauder R, Gunthcrt U: CD44 isoforms: Impact on lymphocyte activation and differentiation, Immunologist 1995:3:78-83.
14. Shimizu Y, van Scventcr GA, Siraganian R, Wahl L, Shaw S: Dual role of the CD44 molecule in T cell adhesion and inactivation, J Immunol 1989:143:2457-2463.
15. Tanaka Y, Adams DH, Hubschcr S, Hirano H, Siebcnlist U, Shaw S: T cell adhesion induced by proteoglycan-immobilized cytokine MIP-I beta, Nature 1993:361:79-82.
16. Kaplan D: Autocrine secretion and the physiological concentration of cytokines, Immunol Today 1996:7:303-304.
17. Lawrence MB, Springer TA: Leukocytes roll on a selcctin at physiological llow rates: Distinction from and prerequisite for adhesion through integrins, Cell 1991;65:859-873.
18. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm, Cell 1994:76:301-314.
19. Emancipator SN, Lamm ME: Enzyme therapy of experimental glomerulonephritis: in An-drcucci VE, Dal Canton A (eds): Current Therapy in Nephrology, Dordrecht, Kluwer, 1989.
20. Lasky LA: The homing receptor (LECAM ML-selcctin); in Harlan JM, Lu DY (eds): Adhesion: Its Role in Inflammatory Disease, New York, Freemann, 1992. pp 43-64.
21. Lictz K, Heidland A: Trypsin inhibits tumor necrosis factor-alpha release by murine macrophages stimulated with advanced glycosylated end products, in press.
22. Stamenkovic I, Amiot M, Pesando JM, Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family, Cell 1989;46:1057-1062.
23. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells, Cell 1991;65:13-24.
24. Batkin S, Taussig SJ, Szekerezes J: Modulation of pulmonary metastasis (Lewis lung carcinoma) by bromelain, an extract of the pineapple stem (Ananas comosus), Cancer Invest 1988:6: 241-242.
25. Batkin S, Taussig SJ, Szekerezes J: Antimcta-static effect of bromelain with or without its proteolytic and anticoagulant activity, J Cancer Res Clin Oncol 1988:114:507-508.
26. Ustcr S, Rimpler M: Influence of proteolytic treatment on the lectin-binding capacity of tumor cells, Forsch Komplementarmed 1995:2: 190-195.
27. Jutila MA, Kishimoto TK, Finken M: Low-dosc chymotrvpsin treatment inhibits neutrophil migration into sites of inflammation in vivo: Effects on Mac-1 and MEL-14 adhesion protein expression and function, Cell Immunol 1991:132:201-214.
28. Back AL, Gollahon KA, Hickstcin DD: Regulation of expression of the leukocyte intcgrin CDIIa (LFA-I) molecule during differentiation of HL-60 cells along the monocyte/macro-phage pathway, J Immunol 1992:148:710-714.
29. Todd RF, Amaout MA, Rosin RE, Crowley CA, Peters WA, Babior BA: Subcellular localization of the large subunit of Mol (Mol alpha: formerly gp 110), a surface glycoprotein associated with neutrophil adhesion, J Clin Invest 1984;74:1289-1290.
30. Diamond MS, Springer TA: The dynamic regulation of integrin adhesiveness (review article), Curr Biol 1994;6:506-517.
31. van Koovk Y, Weder P, Heije K, de Waal Malefijt R, Figdor CG: Role of intracellular Ca-* levels in the regulation of CD 11 a/CD 18 mediated cell adhesion, Cell Adhcs Commun 1993;1:21-32.
32. Timoncn T, Gahmberg CG, Patarrayo M: Participation of CD1 la-c/CDI8. CD2 and RGD-binding receptors in endogenous and interleu-kin-2-stimulated NK activity of CD3-ncgative large granular lymphocytes, Int J Cancer 1990: 46:1035-1040.
33. Timoncn T, Jaaskelaincn J, Maenpaa A, Hc-lander T, Malygin A, Kovancn P: Growth requirements, binding and migration of human natural killer cells, Immunol Scr 1994:61:63-72.
34. Scott CF, Bolender S, McIntyre GD, Holldack J, Lambert JM, Vcnkatesh YP, Morimoto C, Ritz J, Schlossmann SF: Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells, J Immunol 1989; 142:4105-4112.
35. Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz J: Human natural killer cell adhesion molecules-Differential expression after activation and participation in cvtolysis, J Immunol 1990;145:3194-3201.
36. Wcrfel T, Witter W, Gotzc O: CDllb and CDIlc antigens are rapidly increased on human natural killer cells upon activation, J Immunol 1991.147:2423-2427.
37. Ferrini S, Sforzini S, Camhiaggi A, Poggi A, Meazza R, Cancvari S, Colnaghi ML, Moretta L: The LFA-I/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes, Int J Cancer 1994:56:846-852.
38. Liu JH, Wei S, Blanchard DK, Djeu J Y: Restoration of the lytic function in a human natural killer cell line by gene transfection, Cell Immunol 1994:156:24-35.
39. Morisaki T, Torisu M: Enhanced adherence activity of OK-432-induced peritoneal neutro-ph ils to tumor cells correlates to thei r increased expression of CDllb/CD18. Clin Immunol lmmunopathol 1991:59:474-486.